Temporin-PE [P3Y]

General Information


DRACP ID  DRACP00808

Peptide Name   Temporin-PE [P3Y]

Sequence  FLYIVAKLLSGLL

Sequence Length  13

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP Membrane-targeted



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
NCI-H157 Lung squamous cell carcinoma Carcinoma IC50=3.398µM MTT assay 24h 1
U-251MG Astrocytoma Carcinoma IC50=3.520µM MTT assay 24h 1
PC-3 Prostate carcinoma Carcinoma IC50=27.62µM MTT assay 24h 1
MDA-MB-435S Amelanotic melanoma Carcinoma IC50=9.864µM MTT assay 24h 1

Hemolytic Activity  Horse erythrocytes: 50% Hemolysis=526.5µM

Normal (non-cancerous) Cytotoxicity  HMEC-1: IC50=40.30µM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00808

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C73H120N14O16

Absent amino acids  CDEHMNPQRTW

Common amino acids  L

Mass  166408

Pl  9.3

Basic residues  1

Acidic residues  0

Hydrophobic residues  9

Net charge  1

Boman Index  3020

Hydrophobicity  199.23

Aliphatic Index  210

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  1490

Absorbance 280nm  124.17

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 29191658

Title  Identification and target-modifications of temporin-PE: A novel antimicrobial peptide in the defensive skin secretions of the edible frog, Pelophylax kl. Esculentus

Doi 10.1016/j.bbrc.2017.11.173

Year  2018

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.